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ABSTRACT 
Helicobacter pylori is the most common human gastric pathogen, colonizing 
half of the world's population. Helicobacter suis colonizes the stomach of 60-
95% of pigs at slaughter age and it is the most prevalent non-Helicobacter 
pylori Helicobacter species found in the human stomach causing severe gastric 
disorders. The first barrier that gastric pathogens encounter is the mucus layer, 
of which the main components are highly glycosylated mucin glycoproteins. 
Mucins carry a high diversity of mucosal glycan chains terminating with 
glycan structures that vary between species, individuals and tissue locations 
and provides an extensive repertoire of interaction surfaces for bacteria. 
In this thesis, we describe a constant dynamic interplay between Helicobacter 
spp. and host gastric mucins. Helicobacter infection induces changes in host 
gastric mucin composition and glycosylation, and these alterations affect the 
binding avidity, growth and gene expression of the bacteria. The mucin 
interaction with pathogens is mediated by its glycan composition and shows 
high inter-individual difference. We show that H. pylori and H. suis bind to 
human and pig gastric mucin glycans and glycolipids via different binding 
modes and with different specificity. H. suis binding to gastric mucins and 
glycolipids occurs via two modes of adhesion: to structures with terminal 
galactose at both neutral and acidic pH, and to negatively charged structures at 
acidic pH. These binding modes enable H. suis adhesion to mucins at lower 
pH close to the gastric lumen and in parietal cells and a more intimate adhesion 
to mucin glycans and glycolipids closer to the host epithelial cells. 
We demonstrated that mucins play important role in host defense mechanism 
against gastric pathogens. Mucins are able to limit bacterial growth by 
adhesion and aggregation of H. pylori and they affect the adhesin gene 
expression of the bacteria. Helicobacter infection changes host mucin 
glycosylation in a way that decreases the amount of mucin glycan structures 
targeted in binding and impairs the growth regulating effects of the mucins 
maintaining a more inhabitable niche in the stomach. 
Understanding the dynamic interplay between Helicobacters and host gastric 
mucins and alleviating the impairments of the host defense by these pathogens 
can contribute to the development of preventive strategies against Helicobacter 
infection.  
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 SAMMANFATTNING PÅ SVENSKA 
Helicobacter pylori (H. pylori) är den vanligaste sjukdomsalstrande 
organismen i magen och halva jordens befolkning bär på denna bakterie. 
Helicobacter suis (H. suis) är nära besläktad med H. pylori. H. suis koloniserar 
grisens mage och är även den vanligaste icke-H. pylori Helicobacter-arten i 
magen hos människa. Infektion med både H. pylori och H. suis orsakar 
inflammation magen och kan leda till magsår och magcancer. Behandling av 
dessa infektioner med antibiotika blir alltmer problematisk på grund av den 
globala ökningen av förvärvad antimikrobiell resistans. Sjukdomsalstrande 
organismer i lantbruksdjur utgör ett hot mot människors hälsa både på grund 
av att zoonotiska bakterier såsom H. suis kan infektera både människor och 
lantbruksdjur och på grund av att antibiotikabruk i djur ökar belastningen av 
antibiotikaresistenta bakterier i omlopp. Den vanligaste vägen bakterier 
kommer in i kroppen på är via slemhinnan. Denna yta är täckt av ett 
kontinuerligt utsöndrat slem som tvättar bort bundna partiklar. 
Huvudkomponenterna i detta slem är utsöndrade muciner. Mucinerna bär ett 
stort antal kolhydratstrukturer, vilket ger många potentiella ställen för bakterier 
att binda till. 
I denna avhandling har vi visat att H. suis i likhet med H. pylori lever i 
slemlagret som täcker magslemhinnan. Båda dessa bakterier binder till 
muciner, fast till olika kolhydratstrukturer på mucinerna och därigenom binder 
de till olika muciner. Infektion och inflammation kan orsaka kvalitativa och 
kvantitativa förändringar i kolhydratstrukturerna som sitter på muciner. 
Eftersom bakteriens bindning, tillväxt och genuttryck påverkas av mucinernas 
kolhydratstrukturer förändrar detta relationen mellan bakterien och värden. Vi 
visade att mucinerna, förutom att bära antimikrobiella glykanstrukturer, kan 
begränsa bakteriell tillväxt genom att binda bakterierna. Helicobacter spp. 
infektion kan minska mängden kolhydratstrukturer som binder till H. suis och 
kan försämra de tillväxtreglerande effekterna av mucinerna, vilket kan leda till 
en mer  gästvänlig nisch för H. suis i magen. Vi observerade ett dynamiskt 
samspel mellan Helicobacter spp. och värdmuciner. Vi tror att störning av 
dessa värd-mikrob interaktioner och utveckling av strategier för att förändra 
slemhinnans beteende vid infektion skulle kunna användas både förebyggande 
och som ett alternativ till antibiotika i framtiden.
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 1 Introduction 
1 INTRODUCTION 
1.1 Mucus 
An adherent mucus layer covers the epithelial surfaces of the eye and 
gastrointestinal, respiratory and reproductive tracts in order to protect the 
mucosa from mechanical damage or entrance of harmful chemicals, such as 
drugs, toxins and heavy metals (1-3). In the stomach and duodenum, the mucus 
contributes to surface neutralization of luminal acid by mucosal bicarbonate 
secretion (4) and prevents access of luminal pepsin to the mucosal surface (5). 
The viscous mucus layer is the first barrier in the gastrointestinal tract nutrients 
and enteric drugs must interact with and diffuse through, in order to gain access 
to their targeted organs through the circulatory system (6).  
The thickness of the mucus layer varies greatly among organs, ranging 
between 70-100 µm in the oral cavity (7), approximately 250 µm in the 
stomach, 150-400 µm in the small intestine and reaching 800-900 µm in the 
colon (8). In the gastrointestinal tract, the mucus is continuously cleared by the 
peristaltic movement of luminal food and faecal material and can be rapidly 
replaced from goblet cells by continuous secretion or by compound exocytosis 
in response to chemical or physical irritation (8-10). Mucus consists 
approximately 95% water but it also contains salts, lipids (11) and proteins 
with protective function, such as lysozymes, immunoglobulins, defensins, 
growth factors and trefoil factors (12-14). The main component of the mucus 
is the gel-forming mucin glycoprotein, which is responsible for its viscous 
properties (6, 15). 
1.2 Mucins 
Mucins are highly glycosylated glycoproteins with a molecular weight ranging 
between 0.5 and 20 MDa (6). Mucins consist of a protein core with tandemly 
repeating amino acids rich in serine and threonine, where O-linked 
carbohydrate chains are added in the Golgi apparatus during biosynthesis (16). 
The two major types of mucins are transmembrane and secretory mucins. 
Transmembrane (cell-surface) mucins are located on the apical surface of the 
mucosal epithelial cells. In the human gastrointestinal tract, cell surface mucins 
include MUC1, MUC3, MUC4, MUC12, MUC13, MUC15, MUC16 and 
MUC17 (17). They participate in mucosal defense translating external stimuli 
to cellular responses (18). They can also play an important role under host-
pathogen interactions (19). The expression of MUC1 is upregulated in 
Helicobacter spp.-host interaction in the mucus niche 
 
 
Introduction 2  
response to infection (20) and acts as a decoy to limit adhesion of the bacteria 
to the cell surface (21). Secretory mucins are one of the major components of 
the extracellular mucus barrier and they are characterized by high molecular 
weight. They can be gel-forming (MUC2, MUC5AC, MUC5B, MUC6 and 
MUC19) or non-gel-forming secreted mucins (MUC7). The gel-forming 
mucins have cysteine-rich motifs that are important in the formation of 
oligomers via inter-molecular disulphide bonds (22). In a healthy human 
stomach, MUC5AC and MUC6 are the major gel-forming mucins located in 
the surface and glandular region, respectively (23), whereas in the intestine the 
main secreted mucin is MUC2. In the gastrointestinal tract, secretory mucins 
are produced  and secreted by mucous cells of glandular tissues and by goblet 
cells which are specialized epithelial cells (24). The intestinal goblet cells 
migrate from the bottom of the crypts to the villus tip where the mucus shed to 
the lumen and they constantly get replaced (25). The migration along the crypt-
surface axis causes changes in morphology and mucin composition of the 
goblet cells (26, 27). Mucin secretion can happen via vesicle secretion or 
compound exocytosis and can be regulated by numerous environmental 
stimuli, including cholinergic agonist, hormones, neurotransmitters and 
intracellular messengers, such as Ca2+ and cAMP (28, 29). In response to 
infection, both innate and adaptive immunity can regulate the expression of 
mucins. Inflammatory cytokines, such as IL-1β, IL-4, IL-6, IL-9, IL-13, IFNγ, 
tumor necrosis factor (TNF), nitric oxide and granulocyte proteases can 
directly upregulate the expression of mucins (30).  
1.3 Mucin glycosylation 
Posttranslational modifications of proteins by glycosylation can occur in N-
linked and O-linked form. Mucin-type O-glycosylation takes place in the Golgi 
complex and is initiated by the addition of α-N-acetylgalactosamine (GalNAc) 
to the hydroxyl group of Ser/Thr side chains of the folded protein (31, 32). The 
complex oligosaccharides on proteins have three regions: core region (core 1 - 
core 8), backbone region (type 1 and type 2) and peripheral region. This latter 
region can be terminated by fucose, galactose, GalNAc or sialic acid residues, 
forming histo-blood group antigens such as A, B, H, Lewis a (Lea), Lewis b 
(Leb), Lewis x (Lex), Lewis y (Ley), as well as sialyl-Lea and sialyl-Lex 
structures (33) (Table 1). The structure of carbohydrates depends on 
glycosyltransferases expressed in the cells (34). The mucin oligosaccharide 
terminal structure varies between species (35), individuals (36) and between 
tissue locations within one individual (37, 38). For instance, type 1 blood 
group-related antigens are expressed in the cells of the surface epithelium, 
whereas type 2 antigens are found mainly in the glandular region of the human 
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gastric mucosa (39). The majority of normal gastric mucin O-glycans are 
neutral and fucosylated (36), increased sialylation and /or sulphation as well as 
expression of Tn and T antigens can indicate aberrant or incomplete 
glycosylation (40). 
Mucin O-glycans contribute up to 80% of the molecular weight of mucins (6). 
The high level of glycosylation enables mucins to function as a protective 
barrier by lubricating the epithelium (41) and preventing the degradation of the 
protein backbone by proteases (42). Mucin glycans can modulate cell adhesion 
(43), serve as ligands for cell surface receptors (44) and take part in host-
pathogen interaction (20, 45, 46).  Glycan structure alterations are associated 
with many pathological conditions. Cancer associated mucin glycosylation 
changes have been reported in tumor tissues from different organs (47, 48) and 
these modifications can be potentially used as biomarkers of the development 
or progression of tumors (49-51). Bacterial infection can also alter mucin 
production and glycosylation quantitatively as well as qualitatively at both 
cellular and subcellular level (52-54).  
Histo bloodgroup antigens Glycan structure 
  
 Blood group H Fucα1-2Galβ1-   
 Blood group A Fucα1-2(GalNAcα1-3)Galβ1-  
 Blood group B Fucα1-2(Galα1-3)Galβ1-  
 Lewis a (Lea) Galβ1-3(Fucα1-4)GlcNAcβ1-  
 Lewis b (Leb) Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1- 
 Sialyl-Lea NeuAc(α2-3)Galβ1-3(Fucα1-4)GlcNAcβ1- 
 Sialyl-Lex NeuAcα2-3 Galβ1-4(Fucα1-3)GlcNAcβ1- 
 Lewis x (Lex) Galβ1-4(Fucα1-3)GlcNAcβ1-  
 Lewis y (Ley) Fucα1-2Galβ1-4(Fucα1-3)GlcNAcβ1- 
  
Table 1. Histo-blood group antigens carried by mucin O-glycans. 
1.4 Pig gastric mucins 
The stomach mucosa of pigs can be divided into two main parts: a glandular 
part (containing cardiac gland zone, fundic gland zone and antrum with pyloric 
glands) and a non-glandular part called pars esophagea that is covered by a 
stratified squamous epithelium (55). The non-glandular region and the cardiac 
gland zone have a pH around 5-7 due to the presence of saliva and cardiac 
gland bicarbonate secretions (56), while the fundic and pyloric glands provide 
lower pH in the distal part of the stomach with high inter-individual variability 
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(57). The mucus secreted in the different regions of the pig stomach shows big 
variations regarding density, size, viscosity and amino acid and glycan content 
(58-60). Mucins produced by the surface epithelium also differs from the gland 
mucins in apoprotein content and length of the glycosylated domains 
indicating that the surface epithelium and the glands produce different mucins, 
which mucins might represent the porcine equivalents of the human MUC5AC 
and MUC6 mucins, respectively (61).  
Alterations in pig mucins can be induced by certain environmental factors and 
conditions, e.g., weaning associated mucin glycosylation changes play an 
important role in the adaptation to new dietary constituents, physical 
environment as well as commensal and pathogenic bacteria (62, 63). In weaned 
pigs, increased mucin secretion occurs (64) and an elevated level of 
fucosylated mucin glycans has also been reported (62). These glycosylation 
changes can be further modified with dietary changes (63-66) and by microbial 
activities (67).  
1.5 Host-pathogen interactions in the mucus niche  
The mucus layer serves as the first barrier between pathogens and host cells on 
several organs providing a surface for host-pathogen interaction. Microbes 
commonly interact with the glycan structures of the host glycocalyx to colonize 
mucosal surfaces (68). The high variety of mucin oligosaccharides forms an 
extensive repertoire of attachment sites for bacteria (69). Microorganisms 
attach to mucosal glycans via adhesins with different carbohydrate specificities 
(46, 70, 71) and the high diversity of mucin glycan chains can lead to region-
specific colonization by the bacteria (72). Binding of pathogens to the cell 
surface mucins supports the barrier function of mucus by releasing the 
extracellular domain together with the bound bacteria from the cell surface, 
acting as a releasable decoy (21).  
Mucus can serve as a reservoir for numerous pathogens (73-75), and be used 
as a matrix for replication and colonization (76). Mucus can provide an 
important source of nutrients for bacterial growth (77, 78). A number of 
bacterial strains are able to degrade mucins by producing specific enzymes, 
including glycosidases, sulphatases, sialidases and use the released glycans as 
energy source (79-84).  The microbiota inhabiting the mucus layer is able to 
modulate the mucus niche in a way that it becomes beneficial for the bacteria. 
Studies on germ-free mice have revealed that Bacteroides thetaiotaomicron, 
by secreting signaling molecules, induces the expression of fucose on cell 
surface glycoconjugates and these fucosylated glycans can be utilized by these 
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bacteria as carbon source (67). Some pathogens can also alter the pH of the 
mucus in their microenvironment decreasing its viscoelasticity that can 
facilitate bacterial motility (85). In response to infection, host mucins have the 
ability to affect the behavior of the bacteria by regulating the growth and gene 
expression of pathogens (86-88) which leads to a constant dynamic host-
pathogen interaction. 
1.6 Helicobacter pylori 
Helicobacter pylori (H. pylori) is a Gram-negative spiral-shaped 
microaerophilic bacterium that colonizes the stomach of half the human 
population. In 1983, Dr. J. Robin Warren and Dr. Barry Marshall reported the 
hypothesis that peptic ulcers are caused by spiral shaped bacteria in the 
stomach and they were the first who successfully isolated H. pylori from 
gastric biopsies (89). H. pylori infection usually occurs at a very young age 
and becomes persistent (90). Although the majority of H. pylori infections are 
asymptomatic, infected patients may develop non-ulcer dyspepsia, peptic ulcer 
disease, adenocarcinoma, and mucosa-associated lymphoid tissue (MALT) 
lymphoma (91-93). The International Agency for Research on Cancer (IARC) 
classified H. pylori as a class I carcinogenic agent based on epidemiologic 
evidence (94). The clinical outcome of H. pylori infection can be determined 
by the interplay of several bacterial, host or environmental factors, reviewed 
in (95). 
1.7 H. pylori interaction with mucins 
H. pylori colonizes the human gastric mucosa and is predominantly located in 
the mucus layer that covers the surface epithelial cells and only a small 
percentage are found in close association to the epithelial cells (96). Because 
of the rapid gastric mucus turnover, the bacteria need to develop strategies to 
avoid being shed into the gastric lumen and to maintain a stable niche in the 
stomach. The pH gradient across the gastric mucus layer ranges between 2 and 
7, being very acidic close to the lumen and approximately neutral at the 
epithelium. H. pylori can use the pH gradient in the mucus for chemotactic 
orientation, which plays an important role in the persistence in the stomach 
(97). H. pylori secretes urease enzyme, which is responsible for the tolerance 
of the acidic environment and facilitates the motility of H. pylori in the gastric 
mucus (98). Experiments using urease-negative H. pylori mutants 
demonstrated that urease activity is crucial for gastric colonization and survival 
of the bacteria (99). Urease level detection is a commonly used rapid diagnostic 
tool for H. pylori infection in the stomach (100).  
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1.8 H. pylori adhesion to mucins 
H. pylori adhesion to gastric mucins allows the bacteria to gain access to 
nutrients from host tissues (71, 101), and triggers host inflammatory responses 
(102-104). Binding to membrane bound mucins protects the bacteria from 
being shed by the passage of luminal content (21), which is crucial for 
maintaining a stable niche in the mucus layer. The glycan environment that H. 
pylori is exposed to constantly changes in response to different environmental 
effects, such as bacterial infection and development of diseases (53, 105-107).  
H. pylori requires a wide range of adhesive molecules to adapt to the dynamic 
microenvironment in the stomach. The genome of H. pylori codes for 
numerous outer membrane proteins (108) which allows adhesion to several 
different carbohydrate structures on mucins. H. pylori binds to glycan 
structures present on both glycolipids and mucins, the former providing a more 
intimate adhesion to the host cells and the latter can serve as a decoy and be 
part of the host defense system (21, 71, 109). 
The blood group antigen binding adhesin (BabA) recognizes fucosylated 
structures, such as Leb and H-type 1 antigen (46, 110) and mediates a high 
affinity bacterial binding to these structures (71). H. pylori strains expressing 
BabA have been considered more virulent, since they are more commonly 
associated with the development of severe gastric diseases (110-113). BabA-
mediated binding can be influenced by certain environmental factors. It has 
been shown that BabA-Leb adhesion is acid sensitive but fully reversible by 
pH neutralization (114). This type of binding can also be reduced by treatment 
with the redox-active pharmaceutical N-acetylcysteine that has been suggested 
to be used in H. pylori eradication therapy development (115). 
The sialic acid binding adhesin (SabA) mediates adhesion to α2,3-sialylated 
structures, such as sialyl-Lea and sialyl-Lex (116). In a healthy human stomach, 
sialyl-Lex antigen containing glycoconjugates are rarely expressed, whereas it 
has been shown to be upregulated after H. pylori infection and inflammation 
(116, 117). The acid responsiveness of sabA expression can be controlled by 
the ArsRS two-component signal transduction system (118, 119). In vitro 
studies demonstrated that sabA transcription is repressed by the acid-
responsive ArsS and the H. pylori J99 isogenic mutant lacking ArsS histidine 
kinase locus (J99ΔarsS) had a 10 fold SabA-dependent binding to human 
gastric cells compared to the wild-type strain (118).  
Several other adhesion molecules have been described to mediate H. pylori 
binding (Table 2). The lacdiNAc specific adhesin (LabA) has been suggested 
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to bind to the lacdiNAc structure (GalNAcβ1-4GlcNAc) on gastric mucins 
(120). The neutrophil activating protein A (NapA) has been shown to mediate 
binding to sulphated carbohydrate structures on high-molecular-mass salivary 
mucins (121, 122) as well as to Lex blood group antigen (121) and to sialylated 
glycans (122). Studies using isogenic mutants of H. pylori discovered a role of 
adherence-associated lipoprotein A and B (AlpA and AlpB) in binding to the 
host extracellular molecule laminin (123, 124) and a role of outer inflammatory 
protein A (OipA) in binding to gastric epithelial cells (125), although, the 
target receptor of the latter has not yet been identified. The Helicobacter pylori 
adhesin A (HpaA) lipoprotein has been characterized as an N-
acetylneuraminyllactose-binding hemagglutinin (126). The HopZ membrane 
protein of H. pylori has also been associated with adhesion to gastric cancer 
cells (127). The type IV Cag secretion apparatus can also contribute to H. 
pylori adhesion carrying the CagL adhesive protein that has been shown to 
mediate α5β1 integrin binding on gastric epithelial cells (128).  
Lipopolysaccharide (LPS) on the surface of most H. pylori strains express 
Lewis blood group antigens with structural identity to the ones on host cells 
(129, 130). This molecular mimicry helps the survival of H. pylori in the 
stomach making the bacteria less recognizable by host immune cells (131).  
The most likely mechanism of adhesion of H. pylori-expressed O-glycans to 
host cells happens via the galactoside-binding lectine, galectin-3 (132). H. 
pylori LPS is able to bind to surfactant binding protein D (SP-D) which is a C-
type lectin involved in antibody-independent pathogen recognition and 
clearance (133).  
Adhesion molecule Adhesion target Reference 
BabA Leb, H-type-1 (46, 110) 
SabA Sialyl-Lea, sialyl-Lex (116) 
LabA LacdiNAc (120) 
NapA Sulphated, sialylated glycans, Lex (121, 122) 
AlpA, AlpB Laminin (123, 124) 
OipA Unknown (125) 
HpaA N-acetylneuraminyllactose (126) 
HopZ Unknown (127) 
HopQ CEACAM (134, 135) 
CagL Integrin (128) 
LPS Galectin-3, SP-D, E/L-selectin (132) 
 
Table 2. Adhesion molecules and adhesion targets of H. pylori. 
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Bacteria that penetrate the mucus layer get in contact with the large membrane-
bound mucins before they reach the host tissue (136, 137). In a healthy human 
stomach, MUC1 is the most highly expressed cell surface mucin. MUC1 serves 
as an adhesion target for H. pylori since it can carry ligands for the BabA and 
SabA adhesins (21). After bacterial adherence, MUC1 can act as a releasable 
decoy shedding together with the bound bacteria from the epithelial surface to 
the gastric juice (19, 21). 
1.9 Effects of mucins on H. pylori growth 
Besides serving as attachment sites, mucins can be important for bacterial 
colonization by providing energy source for the bacteria. Depending on the 
origin and type of the mucin, it can have a stimulatory or inhibitory effect on 
bacterial growth (86). In vitro proliferation assays revealed that culturing H. 
pylori in the presence of purified human gastric mucins from tumor tissue and 
from surface mucosa had a growth promoting effect, whereas mucins from the 
glandular region tended to inhibit the growth of H. pylori (86). Glandular 
mucins with α1,4-linked N-acetylglucosamine (α1,4-GlcNAc) terminating O-
glycans have been suggested to have an antimicrobial effect by inhibiting the 
synthesis of a vital cell wall component, cholesteryl-α-D-glucopyranoside 
(138, 139). The α1,4-GlcNAc glycan structure can be found on MUC6 
produced by gland mucus cells which can explain H. pylori colonizing the 
surface mucous layer and only rarely appear in deeper mucus (139).  
1.10 H. pylori infection induced mucin glycosylation 
changes 
H. pylori infection can alter the expression of normal gastric mucins (53) and 
impair mucin production and turnover rate (54). Prolonged infection with this 
pathogen showed a decrease in fucosylation and an increase in sialylation of 
mucin glycans in human stomach (140). Increased sialyl-Lewis antigen 
expression have also been observed in H. pylori infected rhesus monkeys one 
week after infection where the glycosylation returned to baseline level by 10 
months post-infection (107). In addition, increased sialyl-Lewis antigen 
expression upon H. pylori infection was observed in mice and mongolian 
gerbils (141-143). These alterations in mucin glycosylation enable further H. 
pylori infection by increasing receptors for the SabA adhesion molecule (144). 
These mucin glycosylation changes can be explained by the ability of H. pylori 
to alter the expression of several genes involved in glycan biosynthesis. 
Infection experiments on human gastric cell lines demonstrated that H. pylori 
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infection alters the expression of GlcNAc-transferase (β3GnT5) gene that 
drives the biosynthesis of sialyl-Lex (145).  
1.11 Helicobacter suis  
Tightly coiled spiral shaped bacteria in the pig stomach were first described by 
Mendes et al. and Queiroz et al. (146, 147). The temporary name of this 
bacterium was ‘Gastrospirillum suis’ because of its morphological similarity 
to the bacterium ‘Gastrospirillum hominis’ (148). However, sequencing of the 
16S rRNA gene of this bacterium revealed that it belongs to the Helicobacter 
genus and the bacterium was renamed as ‘Candidatus Helicobacter suis’ (149). 
Helicobacter suis is a Gram negative tightly coiled spiral-shaped bacterium 
that requires highly enriched biphasic medium at pH 5 and a microaerobic 
atmosphere for in vitro growth (150). In its main host, the pig, H. suis colonizes 
mainly the antrum and the fundic gland zone of the stomach (151) and the 
presence of H. suis DNA was also shown in the pars oesophagea (152). The 
prevalence of H. suis in pigs gradually increases with age reaching up to 90% 
at slaughter age (150, 153). In pigs, H. suis infection is associated with chronic 
gastritis (55), decreased daily weight gain (154) and the presence of ulcers in 
the pars oesophagea (155). H. suis infection may result in increased gastric 
acid secretion, contributing to the contact of the non-glandular part of the 
stomach with hydrochloric acid (55). H. suis can often be found in close 
contact with the acid producing parietal cells (156, 157) and they are able to 
affect the viability and function of these cells (158). The outcome of H. suis 
infection in pigs was shown to be dependent on the phase of infection and the 
age of the pigs (159). 
H. suis is the most prevalent non-Helicobacter pylori Helicobacter (NHPH) 
species in the human stomach, with a prevalence ranging between 0.2 and 6%, 
which refers to its zoonotic importance (55). Pigs may serve as source of 
infection for humans by direct contact or by consuming raw or undercooked 
meat (160). Direct human-to-human transmission of H. suis has not yet been 
reported. In the human host, H. suis can contribute to the development of peptic 
ulcer disease, gastric mucosa-associated lymphoid tissue (MALT) lymphoma 
and chronic gastritis (161). The risk of developing MALT lymphoma after 
infection with NHPH species is higher than after H. pylori infection (162).  
Apart from pigs and humans, H. suis infection has also been described in 
rhesus monkeys and cynomolgus monkeys (163) where it caused relatively 
mild gastric disorders (164, 165).  
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2 AIM 
General aim: 
The overall aim of the thesis was to investigate the dynamic interplay between 
Helicobacter spp. and host gastric mucins. A better understanding of this host-
pathogen interaction can contribute to the development of therapeutic 
strategies that can be used to manage Helicobacter infection.  
Specific aims: 
 To investigate the relationship between H. pylori adhesin 
mediated binding, aggregation, growth and adhesin gene 
expression using purified human gastric mucins and synthetic 
glycoconjugates. 
 
 To identify and characterize pig gastric mucins, investigate H. 
suis binding to pig and human gastric mucins and glycolipids 
and define bacterial binding-active structures on mucins.  
 
 To study the effect of experimental H. suis infection on pig 
gastric mucin glycosylation. 
 
 To study how Helicobacter spp. infection related mucin 
glycosylation changes affect H. suis binding and growth. 
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3 METHODOLOGY 
The methods used in the thesis are described in details in the attached papers. 
Here I discuss reasons behind the choice and required optimization and 
adjustments of certain methods. 
3.1 Bacterial growth detection 
Mucins can promote or inhibit bacterial growth depending on the source and 
the type of the mucin. To study the effect of purified gastric mucins on the 
growth of different Helicobacter strains, we cultured the bacteria in the 
presence or absence of mucins. Optical density (OD) is a widely used measure 
of bacterial growth with the interpretation that the OD value of bacteria is 
directly related to the bacterial cell count. Although this method appears 
accurate in many cases, we have discovered that several H. pylori cultures with 
strong binding to the added mucins resulted in high OD values despite low 
colony forming unit (CFU) counts which can be explained by bacterial 
aggregate formation (Paper I). If the aggregates are not fully dispersed prior to 
the CFU plating, several bacteria can appear as one colony leading to an 
enhancing error in OD measurements, and a diminishing error using the CFU 
counting method. Another disadvantage of the bacterial growth detection with 
OD measurement is that this method does not give information about the 
viability of the bacteria (i.e. the ratio of live and dead cells in the bacterial 
culture) that makes this method less informative about the growth response of 
bacteria to different agents. Therefore, there was a need to develop a method 
for the accurate assessment of H. pylori growth and viability. The metabolic 
activity of bacteria can be measured by adding alamarBlue cell viability 
reagent to the bacterial cultures (166). Our growth experiments demonstrated 
that, the relationship between the alamarBlue signal and CFU counts is similar 
to the relationship between OD measurement and CFU counts in the absence 
of bacteria binding elements in the culture, thus metabolic activity 
measurement with alamarBlue seems to be accurate in H. pylori growth 
detection.  
The same method, however, could not be used for H. suis growth detection, 
since this pathogen requires a culture media with pH5 for in vitro growth which 
is below the optimum pH for alamarBlue bioassays. Therefore, we needed to 
develop a method that measures the metabolic activity of the bacteria in the 
environment that is crucial for the bacterial growth. For this purpose, we used 
the RealTime-Glo™ viability assay that is a luciferase reaction based assay, 
where the detected light production is proportional to the number of live 
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bacterial cells in the culture media (Paper III). With this method, we can 
continually monitor the bacterial growth while maintaining an optimal 
environment for the bacteria (Figure 1). 
 
Figure 1. H. suis growth detection by RealTime-Glo™ viability assay. H. suis growth 
curve when cultured in the absence (■) or presence of a growth promoting (●) or a growth 
inhibiting (▲) mucin. 
3.2 Bacterial binding detection  
We used four different assays to study bacterial binding to purified mucins, 
glycoconjugates and glycolipids. 
3.2.1 Binding assay using antibody detection (Paper I, II) 
Helicobacter spp. binding to purified mucins and glycocojugates can be 
analyzed in a microtiter-based binding assay using Helicobacter specific 
antibody. In this assay, the samples are coated on 96-well polysorp plates and 
incubated with the bacteria. Helicobacter specific primary antibody and 
horseradish peroxidase conjugated secondary antibody are added to the wells. 
The bound bacteria are visualized by adding 3,3’,5,5’-Tetramethylbenzidine 
(TMB) to the wells that is a substrate for horse radish peroxidase on the 
secondary antibody. After color development, the reaction is stopped with 
0.5 M H2SO4 and absorbance is measured in a microplate reader at 450 nm. 
During the binding evaluation process, the background signal given by the 
binding of bacteria to the plastic wells and the binding of antibody to the mucin 
are subtracted from the detected binding values.  
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3.2.2 Binding inhibition assay (Paper II) 
To investigate the binding of bacteria to monosaccharides that are not 
conjugated to carrier protein, hence cannot be coated on polysorp plates, 
binding inhibition assay was performed. In this method, a mucin with strong 
bacterial binding ability was coated on the 96-well plate and the bacteria were 
pre-incubated with the sugars of interest prior to the incubation with mucins. 
If the glycans that are used during pre-incubation are targets of the bacterial 
adhesins, they are expected to inhibit binding of the bacteria to the mucin 
sample by occupying the binding site of the adhesion molecules. 
3.2.3 Binding to purified mucins and glycoconjugates using 
biotinylated bacteria (Paper II, III) 
The H. suis binding signal detected with the antibody detection method was 
relatively weak compared to the level of adhesion found with H. pylori. The 
low binding signal and high background signal due to the cross-reaction 
between the antibody and mucins was technically challenging, thus we 
performed an adhesion assay using biotinylated bacteria. To avoid damaging 
the adhesins by biotinylation, mild biotinylation of bacteria was performed, as 
previously described (167). Similarly to the binding detection with antibody, 
the mucin and glycoconjugate samples were coated on 96-well polysorp plates, 
and incubated with biotinylated bacteria. Bound bacteria were detected by the 
reaction between biotin carried by the bacteria and horseradish peroxidase 
conjugated streptavidin and the binding was visualized with TMB substrate. 
The results obtained with this method were similar to the results obtained with 
the antibody detection method, but with higher signal to noise ratio. 
3.2.4 Binding of Helicobacter spp. to glycosphingolipids on thin-
layer chromatograms (Paper II) 
Glycolipids can carry similar glycoepitopes as mucins that can serve as binding 
sites for bacteria providing a more intimate bacterial adhesion to the host. The 
use of glycolipids in binding studies simplifies the investigation of the binding 
specificity, since these molecules carry only one glycan, contrary to the 
multiple glycans carried by mucins. Binding detection to glycolipids was 
performed by using 35S-methionine labeled bacteria. The labeling of 
Helicobacter spp. was performed as described (168). The glycosphingolipids 
were separated on aluminum-backed silica gel plates and the bound 35S-labeled 
bacteria were detected by autoradiography. Due to that the low incorporation 
of radioactive label into H. suis made the glycolipid binding results difficult to 
reproduce, we also demonstrated binding of this pathogen to glycoconjugates 
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terminating with the same epitopes using binding methods independent of 
metabolic labeling of the bacteria (i.e. the above methods). 
   Médea Padra 
 
 15 Results and Discussion 
4 RESULTS AND DISCUSSION 
4.1 BabA mediated binding of H. pylori affects the growth 
and gene expression of the bacteria (Paper I) 
The presence of certain gastric mucins in bacterial culture has been shown to 
promote or inhibit H. pylori growth, depending on the type and origin of the 
mucin (86). Mucin molecules carry a vast array of different oligosaccharide 
structures that can be utilized as nutrition source by mucin degrading bacteria, 
hence can stimulate bacterial growth (83, 84, 169). Glandular mucins that carry 
α1,4-GlcNAc terminating O-glycans have been suggested to have an 
antimicrobial effect inhibiting the biosynthesis of a major H. pylori cell wall 
component (138, 139), although, this cannot be the only explanation for the 
growth inhibitory effect of mucins, since not all the mucin samples that inhibit 
H. pylori growth carry this structure (86). To investigate the growth of H. 
pylori in response to mucins and mucin glycans, we cultured the bacteria in the 
presence of Leb and SLex glycoconjugates that are the adhesion targets of H. 
pylori adhesin BabA and SabA, respectively, and in the presence of mucins 
that carry these structures. In these experiments, we used strains with different 
adhesin gene expression: strain J99 that carries both the babA and sabA gene 
and strain P12 that carries the babA gene only. Both strains had stronger 
binding avidity to Leb than to SLex and both strains bound better to the mucin 
derived from healthy stomach that carries Leb and is lacking SLex, than to the 
tumor-derived mucin that carries both Leb and SLex glycan structures. H. pylori 
growth measurement by detecting alamarBlue reduction revealed that Leb-
conjugates decreased the metabolic activity of both H. pylori strains, 
suggesting that adhesion to Leb and to mucins carrying these glycan structures 
inhibit the growth of the bacteria. This hypothesis was supported by further 
binding and growth experiments using adhesin deletion mutants. As expected, 
babA deletion mutants of both strain J99 and P12 had lower binding avidity to 
Leb glycoconjugate and to mucins that carry this structure than the isogenic wt 
strains and they showed low or no binding to SLex. Deletion of babA reversed 
the growth inhibiting effect on strain J99 and enhanced the growth of strain 
P12 in the presence of the mucin and Leb, indicating that strain P12 has a 
positive growth response to mucin glycans, which is suppressed by the BabA 
mediated binding. These results together indicate that the interaction of both 
H. pylori strains with mucin glycans is mediated by BabA and that the effect 
of mucins on bacterial growth is highly dependent on the glycosylation of 
mucins. 
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To visualize the morphology and viability of the bacteria in the presence of 
mucin glycans, the bacterial culture of strain J99 wt and its isogenic mutants 
after co-culturing with Leb and SLex glycoconjugates were stained with 
Live/Dead double staining kit that stains viable and dead bacterial cells in the 
culture media with different colors. This staining revealed aggregate formation 
with J99ΔsabA and J99 wt in the presence of Leb-glycoconjugate, which was 
accompanied by decreased metabolic activity as measured by alamarBlue 
reduction. There was no aggregate formation when J99ΔbabA was cultured in 
the presence of Leb, and it did not affect the metabolic activity of the bacteria. 
Adhesive interaction between bacteria has been shown to be induced by 
unfavorable growth conditions (170, 171), and the role of aggregate formation 
in bacterial resistance towards antimicrobial agents has been also described 
(172). These observations suggest that aggregate formation might be beneficial 
for the bacteria as part of the bacterial survival strategy in response to 
environmental factors. In this thesis, we describe the benefits of bacterial 
aggregate formation for the host and we hypothesize that in addition to 
facilitating washing away the bacteria from the stomach, mucin binding 
controls the pathogen number in the stomach by the growth limiting effect of 
aggregate formation. As it was revealed by Live/Dead staining, the majority of 
the aggregate forming bacteria were alive, suggesting that there is no direct 
antimicrobial effect of aggregate formation, the growth limiting effect can be 
instead explained by the slow replication due to physical hindrance or inter-
bacterial communication.  
Apart from affecting the growth of the bacteria, attachment to mucins can alter 
the expression of H. pylori genes relevant to colonization. We have previously 
shown that culturing H. pylori in the presence of mucins from different 
individuals can affect the adhesin expression of the bacteria (86). Here we 
demonstrated that H. pylori BabA and SabA adhesin expression in response to 
mucins negatively correlates with the binding avidity of the bacteria to these 
mucins. To verify the effect of adhesion on bacterial gene expression, we 
analyzed adhesion gene expression level after co-culturing the bacteria with 
SLex- and Leb-glycoconjugates and we observed that the presence of Leb 
decreased babA expression, whereas the level of this gene was not affected by 
the presence of SLex. The repression of babA gene expression in response to 
Leb binding might be part of the bacterial defense mechanism avoiding 
excessive binding to mucins that would lead to the removal of the bacteria 
along with shedding mucus. Decreasing the amount of adhesins in response to 
binding might serve as a negative feedback loop that can enable long-term 
colonization by H. pylori.  
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4.2 ArsS affects H. pylori growth and BabA-dependent 
binding (Paper I)  
H. pylori expresses the ArsS pH sensor histidine kinase protein that plays a 
role in urease gene transcription and in urease protein delivery in order to 
enhance acid acclimation (173). Increased of SabA expression level has been 
previously shown in an H. pylori strain lacking the ArsS (118). In line with 
these results, we detected increased binding of J99ΔarsS to SLex and to SLex 
containing mucins compared to that of J99 wt and it was accompanied by 
decreased binding to Leb and Leb containing mucins with the arsS deletion 
mutants of both J99 and P12 strains. Deleting the arsS slightly increased BabA 
protein expression in J99ΔarsS, whereas decreased in P12ΔarsS to a similar 
degree. These results suggest that level of BabA-dependent binding is more 
dependent on the topographical localization rather than the number of adhesins 
present on the bacteria. Contrary to the growth inhibitory effect of mucin 
glycans on the H. pylori wt strains, J99ΔarsS and P12ΔarsS growth did not 
decrease in the presence of the mucin samples or Leb glycoconjugate, which 
can be due to the lack of aggregate formation. The adhesion and growth 
experiments using the H. pylori arsS deletion mutants further confirmed the 
role of bacterial aggregate formation in the growth inhibitory effect of mucins.  
4.3 H. suis resides in the mucus layer and can also be 
found associated with parietal cells (Paper II, III). 
In H. pylori infected human stomachs, the majority of H. pylori have been 
detected in the surface mucus layer (96) that protects the bacteria from the low 
acidity in the stomach and provides surface for host-pathogen interactions (70). 
Here we analyzed the mucus layer of the pig stomach and the spatial 
distribution of the pig gastric pathogen, H. suis. On pig gastric tissue sections, 
we detected a thick mucus layer covering the epithelial cells. Antibody 
detection on these sections as well as proteomic analysis on purified gastric 
mucin samples revealed that MUC5AC is the predominant secreted mucin in 
the pig stomach, similarly to the human stomach. We performed fluorescent in 
situ hybridization on pig gastric tissue sections obtained from pigs 
experimentally or naturally infected with H. suis and detected H. suis in the 
mucus layer lining the surface epithelium and throughout the gastric pits. We 
and others also detected this bacterium in close association with the acid 
producing parietal cells (156). These findings suggest that H. suis is exposed 
to neutral pH in the mucus layer closer to the epithelial cells and in the lamina 
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propria and exposed to acidic pH closer to the gastric lumen as well as when 
inside the parietal cells. 
4.4 Gastric mucin glycosylation differs between pigs and 
humans as well as between H. suis infected and non-
infected pigs (Paper II, III) 
H. suis is associated with the development of severe gastric disorders in its 
main host, the pig and also in humans. Since H. suis resides in the gastric 
mucus layer, interaction with mucin glycans can be crucial for colonization 
and survival of the bacteria and can also support the host defense system 
maintaining a dynamic host-pathogen interplay in the stomach. To get a better 
understanding of this host-pathogen interaction, we analyzed the glycosylation 
of purified pig gastric mucin samples by mass spectrometry analysis, and since 
H. suis is of zoonotic importance, we studied the differences between pig and 
human gastric mucin glycosylation. The glycan profile of both pig and human 
mucins showed high inter-individual differences. We detected higher number 
of different glycan structures in the human mucins than in the pig mucins, 
which does not necessarily provide evidence for higher inter-individual 
variability in humans than in pigs, since the pig samples analyzed here only 
include non-infected pig mucins, whereas the human samples also include 
pathological specimens. The length of mucin O-glycans varied between 2 and 
14 residues in pig samples and from 2 to 12 residues in human mucins. Both 
pig and human gastric mucin oligosaccharides were mainly extended core 1 
and core 2 O-glycans, although, structures with core 3 and 4 were also detected. 
The relative abundance of extended core 1 O-glycans was higher in pig than in 
human mucins. The terminal residues on the mucin glycans are usually vital 
parts in mucin-pathogen interaction, therefore we quantified the relative 
abundance of these glycan epitopes on pig and human gastric mucins (Figure 
2A). The most abundant terminal residue was galactose on pig mucin glycans 
and fucose on human mucin glycans. The level of sialylation of gastric mucins 
was low both in pigs and in humans. The relative abundance of mucin glycans 
with terminal galactose were higher in pig mucins, whereas the relative 
abundance of fucose terminating glycans were higher in human mucins. The 
main difference between human and pig glycan terminal epitopes was the level 
of sulphation which was around 50% in pig mucins and very low, around 0.6% 
in the human samples.  
Since H. pylori infection has been shown to trigger qualitative and quantitative 
changes in host gastric mucins (53, 54, 141-143), we studied the alterations of 
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pig gastric mucins in H. suis infection. With mass spectrometry analysis on 
purified pig gastric mucins, we identified that MUC5AC is the major secreted 
mucin in the pig stomach. A decreased level of MUC5AC was detected among 
mucins from H. suis infected pigs compared to the samples from non-infected 
pigs, similarly to the effect of H. pylori infection in the human stomach (53). 
We detected in total 118 different oligosaccharides on the pig gastric mucin 
samples, out of which 18 structures with low fucose and sialic acid content 
were detected only in the non-infected samples and 7 structures containing 
higher fucose and sialic acid level were only detected in the infected group. 
The number of different oligosaccharide structures detected in the mucin 
samples was lower in the infected group, implying a decrease in the number of 
glycan structures on pig gastric mucins upon infection limiting the variety of 
glycan epitopes for bacterial interactions. In mucins from the infected group, 
we detected an increase in the relative abundance of acidic (mostly sulphated) 
and fucosylated glycan structures and a decrease in glycan structures 
terminating with galactose (Figure 2B). These terminal glycan structures play 
important role in the binding and growth of H. suis in the presence of mucins, 
as it is described later in the thesis.  
 
Figure 2. Differences in the relative abundance of terminal glycan epitopes between pigs 
and humans as well as between H. suis infected and non-infected pigs. A. Differences in 
the relative abundance of terminal glycan structures between pig and human gastric mucins 
B. Changes in pig gastric mucin glycosylation upon H. suis infection. Stars indicate 
statistically significant difference between mucin glycans, *, ** and *** indicate p ≤ 0.05, 
0.01 and 0.001, respectively, Two-way ANOVA. 
4.5 H. suis binding to gastric mucins in health and disease 
(Paper II, III). 
We analyzed H. suis binding to purified pig and human gastric mucins at the 
pH range present in the stomach and compared it with the binding of H. pylori 
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to the same human mucins. H. suis and H. pylori binding to purified mucins 
and glycoconjugates showed different pattern both regarding their pH 
preference and glycan specificity (Figure 3). H. suis binding level was highest 
at pH 2 with a gradual decrease towards neutral pH, whereas H. pylori bound 
better at neutral pH.  H. suis and H. pylori bound to the same mucin samples 
as well as glycoconjugates with different avidity, suggesting that the two 
Helicobacter species use different modes of adhesion with different glycan 
specificities. H. pylori binding to mucins has been described to happen via four 
modes of adhesion (70), the most well characterized of which are the BabA 
and SabA mediated binding to Leb and sialylated glycans, respectively. H. suis 
genome analyses revealed that H. suis lacks homologs of BabA and SabA, 
although, contains some OMPs similar to the major OMP families described 
in H. pylori, which might be involved in binding to gastric mucins (161).  Our 
bacterial binding experiments showed that H. suis binding avidity differed 
between the mucin samples investigated. Some samples bound the bacteria 
only at acidic pH, whereas other samples bound also at neutral pH. 
Furthermore, H. suis binding to GuHCl soluble mucins was more pronounced 
than to insoluble ones. The differences in H. suis binding avidity to the 
different mucin samples can be explained by the glycosylation differences 
between the samples.  Here we suggest that H. suis uses two ways of adhesion 
to mucins: one binding mode that is dependent on acidic pH and one that is 
functional also at neutral pH, and both binding modes depend on the glycan 
structures carried by the mucins.  
To find the glycan structures on the mucins that might serve as adhesion targets 
for H. suis, we analyzed the relation between the bacterial binding amplitude 
to the mucins and the abundance of the different glycan structures carried by 
these mucins. We focused primarily on the terminal residues, since these 
glycans are more exposed for bacterial binding. At pH 2, the relative 
abundance of acidic (i.e. sulphated and/or sialylated) glycans correlated with 
the level of H. suis binding, indicating that H. suis can bind to acidic structures 
via charge dependent mode. This hypothesis was also confirmed by H. suis 
binding to the highly charged DNA at pH 2, but not at pH 7. The stronger 
binding avidity to mucins at lower pH cannot be the consequence of protein 
denaturing because not all the mucin samples that were tested bound H. suis at 
low pH. In addition, binding at low pH to DNA also suggests that binding at 
acidic pH occurs to charged structures, not to denatured proteins (Figure 3A). 
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Figure 3. H. suis and H. pylori binding differences regarding pH and glycan specificity. 
A. H. suis binding to purified mucins, glycoconjugates and DNA at pH 2 and pH 7. B. H. 
pylori binding to purified mucins, glycoconjugates and DNA at pH 2 and pH 7. The binding 
values are shown after subtracting background signal (bacteria binding to plastic well). 
Glycolipids can carry similar glycan structures as mucins and they represent a 
more intimate adherence to the host by Helicobacter species. To further 
investigate H. suis binding specificity, we examined H. suis binding to 
glycosphingolipids isolated from porcine stomach, where binding to 
lactotetraosylceramide (Galβ3GlcNAcβ3Galβ4Glcβ1Cer) was detected. To 
confirm the binding specificity to this structure, H. suis binding to Lacto-N-
tetraose (LNT, Galβ3GlcNAcβ3Galβ4Glc) conjugated to human serum 
albumin (HSA) was also tested. In line with the glycolipid binding results, H. 
suis bound to LNT conjugated to HSA at pH 7 and the binding remained 
functional at pH 2. We also demonstrated that binding to pig mucins can be 
inhibited by pre-treating the bacteria with LNT or sialylated LNT. Together 
these data indicate that H. suis can bind to mucins with terminal galactose and 
that acidic modification may have beneficial effects on binding. 
H. pylori induced gastric mucin glycosylation changes have been demonstrated 
to influence the mucin binding avidity of the pathogen (107). The decreased 
Leb level and increased sialylation in the gastric mucosa decrease BabA 
mediated binding and increased the adhesion via SabA and via the charge-
dependent binding modes (70, 107) leading to an overall decreased adhesion, 
since BabA mediated binding is generally higher than binding via SabA. To 
study the effect of Helicobacter infection on the binding avidity of H. suis, we 
used purified pig gastric mucins with or without H. suis infection as well as 
human gastric mucins with and without Helicobacter spp. infection and tested 
H. suis binding to these mucins at acidic and neutral pH. In line with previous 
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observations, H. suis binding to pig gastric mucins was higher at pH 2 than at 
pH 7, regardless of the infection status of the pigs (Figure 4A, B), whereas pH 
did not affect the binding avidity to human gastric mucins. Infection caused a 
decreased H. suis binding avidity to pig gastric mucins at pH 7 (Figure 4B) but 
not at pH 2 (Figure 4A). At neutral pH, the decreased binding after infection 
can be explained by the infection-induced loss of adhesion targets by the 
decreased terminal galactose on mucins and at acidic pH, H. suis also binds via 
charge dependent mode to acidic structures, the abundance of which structures 
increased during infection.  
Bacterial adherence to gastric mucins can serve as important part of the host 
defense mechanism protecting the epithelial cells from the invasion by 
Helicobacters. This hypothesis has been supported by observations where H. 
pylori-infected children and rhesus monkeys secreting mucins with less H. 
pylori binding capacity, develop higher H. pylori density and more severe 
gastritis (107, 174). Our results demonstrate that Helicobacter spp. infection 
decreases the ability of mucins to bind H. suis, thereby avoiding the removal 
of the pathogen from the gastric niche.  
 
Figure 4. H. suis binding and growth in the presence of gastric mucins derived from H. 
suis infected or non-infected pigs. A. H. suis binding to H. suis infected or non-infected pig 
gastric mucin samples at pH 2. B. H. suis binding to H. suis infected or non-infected pig 
gastric mucin samples at pH 7. C. H. suis growth in the presence of gastric mucin samples 
derived from H. suis infected or non-infected pigs. (*p<0.05, ***p<0.001, Two-way 
ANOVA). 
4.6 Helicobacter spp. infection induced mucin 
glycosylation changes increase H. suis growth (Paper 
III).  
The growth of H. pylori has been shown to have different response to mucins, 
depending on the origin and the type of the mucin (86). For instance, when H. 
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pylori is cultured in the presence of mucins that carry glycan structures that the 
bacteria adheres to, the binding-induced aggregate formation slows down the 
growth of the bacteria (Paper I). H. pylori growth can be also inhibited by 
mucins containing α1,4GlcNAc-capped O-glycans (139), a structure that 
primarily is associated with the glandular mucins in the stomach. In this thesis, 
we demonstrated that the growth of H. suis is affected by both porcine and 
human gastric mucins and the response of the bacteria to mucins is dependent 
on the infection status of the individual the mucin was isolated from. Mucins 
from non-infected individuals inhibited the growth of H. suis, whereas mucins 
from infected individuals had a growth promoting effect (Figure 3C). To find 
the possible glycan structures on the mucins that affect the bacterial growth, 
we studied the relationship between the effect of mucin samples on H. suis 
growth and the abundance of glycan structures carried by these mucins. The 
growth inhibitory effect of mucins correlated with the abundance of galactose 
terminating structures and was independent of α1,4GlcNAc-capped O-glycan 
abundance.  Positive correlations between growth and the abundance of acidic 
and fucosylated structures on mucin glycans were observed.  These results 
suggest that Helicobacter spp. infection induced host mucin glycosylation 
changes create a more stable and growth-promoting environment for H. suis, 
and possibly for other Helicobacter species in the stomach that facilitates the 
long term colonization by these pathogens.  
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5 CONCLUSIONS 
In this thesis, we investigated host-pathogen interactions in the mucus niche 
focusing on Helicobacter spp. and gastric mucins. We analyzed the mucus 
alterations in infection and how these changes affect bacterial behavior. Based 
on our results of mucin characterization as well as bacterial adhesion and 
growth assays we can conclude that:  
 Helicobacter spp. infection induces a constant host-pathogen 
adaptation and response process in the stomach. The mucin interaction 
with pathogens is mediated by the mucin glycan composition, which 
is able to inhibit H. pylori growth by adhesion and aggregation of 
bacteria. Mucins also have the ability to influence H. pylori 
pathogenicity by affecting adhesin gene expression.  
 H. pylori and H. suis binding to human and pig gastric mucins differ 
in specificity and pH preference and show high inter-individual 
variation, which can be explained by mucin glycosylation differences. 
 H. suis binding to gastric mucins and glycolipids occurs via two modes 
of adhesion: to structures with terminal galactose at both neutral and 
acidic pH, and to negatively charged structures at acidic pH. These 
binding modes may enable bacterial adhesion at low pH close to the 
gastric lumen and in parietal cells and a more intimate adhesion to 
mucin glycans and glycolipids close to the epithelial cells.  
 Helicobacter spp. infection alters host mucin composition and 
glycosylation in a way that decreases the amount of H. suis binding 
glycan structures on gastric mucins and the H. suis growth regulating 
effects of the mucins. By these alterations, Helicobacters create a more 
stable and inhabitable niche in the stomach which may be crucial for 
long-term colonization.  
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